Skip to main content
Erschienen in:

18.03.2021 | Original Article

Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction

verfasst von: Alessia Gimelli, Alberto Aimo, Emilio Maria Pasanisi, Michele Alessandro Coceani, Alberto Clemente, Michele Emdin, Leslee J. Shaw

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2021

Einloggen, um Zugang zu erhalten

Abstract

Coronary angiography has been recommended in all patients with suspected chronic coronary syndrome and left ventricular ejection fraction (LVEF) ≤35%. The role of ischemia testing, for example, through stress-rest myocardial perfusion scintigraphy (MPS), for risk prediction is not well established.

Methods

We evaluated 1576 consecutive patients referred to MPS and stratified into 3 LV ejection fraction (LVEF) categories: ≤35%, 36–49%, and ≥ 50%.

Results

Patients with LVEF ≤35% were oldest, most often men, and with the highest likelihood of prior early (elective or urgent) coronary revascularization. They had also the highest values or summed stress score (SSS), summed rest score (SRS), and summed difference score (SDS), as well as the highest frequency of significant coronary artery disease, and a greater number of diseased vessels. Follow-up: In this subgroup, 32 cardiovascular death or non-fatal myocardial infarction (MI) (21%), 35 all-cause deaths (22%), and 37 cardiovascular deaths, non-fatal MI, or late revascularizations (27%) were recorded with the shortest survival among all LVEF classes. SRS, SSS, and SDS had very low area under the curve values for the prediction of the 3 endpoints, with very high cut-offs, respectively. SRS and SSS cut-offs predicted a worse outcome in Cox regression models including the number of diseased vessels and early revascularization.

Conclusions

In patients with LVEF ≤35%, SRS and SSS are less predictive of outcome than in patients with better preserved systolic dysfunction, but their cut-offs retain independent prognostic significance from the number of vessels with significant stenoses and from early revascularization.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Gheorghiade M, Sopko G, De LL, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114:1202–13.CrossRef Gheorghiade M, Sopko G, De LL, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114:1202–13.CrossRef
3.
Zurück zum Zitat Panza JA, Holly TA, Asch FM, et al. Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2013;61:1860–70.CrossRef Panza JA, Holly TA, Asch FM, et al. Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2013;61:1860–70.CrossRef
4.
Zurück zum Zitat Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–77.CrossRef Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–77.CrossRef
5.
Zurück zum Zitat Gimelli A, Pugliese NR, Buechel RR, et al. Changes in left ventricle myocardial volume during stress test using cadmium-zinc-telluride cardiac imaging: implications in coronary artery disease [published online ahead of print, 2019 Oct 24]. J Nucl Cardiol. 2019. https://doi.org/10.1007/s12350-019-01930-6. Gimelli A, Pugliese NR, Buechel RR, et al. Changes in left ventricle myocardial volume during stress test using cadmium-zinc-telluride cardiac imaging: implications in coronary artery disease [published online ahead of print, 2019 Oct 24]. J Nucl Cardiol. 2019. https://​doi.​org/​10.​1007/​s12350-019-01930-6.
6.
Zurück zum Zitat Gimelli A, Bottai M, Genovesi D, et al. High diagnostic accuracy of low-dose gated-SPECT with solid-state ultrafast detectors: preliminary clinical results. Eur J Nucl Med Mol Imaging. 2012;39:83–90.CrossRef Gimelli A, Bottai M, Genovesi D, et al. High diagnostic accuracy of low-dose gated-SPECT with solid-state ultrafast detectors: preliminary clinical results. Eur J Nucl Med Mol Imaging. 2012;39:83–90.CrossRef
7.
Zurück zum Zitat Petretta M, Acampa W, Daniele S, et al. Long-term survival benefit of coronary revascularization in patients undergoing stress myocardial perfusion imaging. Circ J. 2016;80(2):485–93.CrossRef Petretta M, Acampa W, Daniele S, et al. Long-term survival benefit of coronary revascularization in patients undergoing stress myocardial perfusion imaging. Circ J. 2016;80(2):485–93.CrossRef
8.
Zurück zum Zitat Gimelli A, Pugliese NR, Kusch A, et al. Accuracy of cadmium-zinc-telluride imaging in detecting single and multivessel coronary artery disease: is there any gender difference? Int J Cardiol. 2019;274:388–93.CrossRef Gimelli A, Pugliese NR, Kusch A, et al. Accuracy of cadmium-zinc-telluride imaging in detecting single and multivessel coronary artery disease: is there any gender difference? Int J Cardiol. 2019;274:388–93.CrossRef
9.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.CrossRef Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.CrossRef
10.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:1810–52.CrossRef Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:1810–52.CrossRef
11.
Zurück zum Zitat Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607–16.CrossRef Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607–16.CrossRef
12.
Zurück zum Zitat Sciagrà R, Bisi G, Santoro GM, Rossi V, Fazzini PF. Nitrate versus rest myocardial scintigraphy with technetium 99m-sestamibi: relationship of tracer uptake to regional left ventricular function and its significance in the detection of viable hibernating myocardium. Am J Card Imaging. 1995;9:157–66.PubMed Sciagrà R, Bisi G, Santoro GM, Rossi V, Fazzini PF. Nitrate versus rest myocardial scintigraphy with technetium 99m-sestamibi: relationship of tracer uptake to regional left ventricular function and its significance in the detection of viable hibernating myocardium. Am J Card Imaging. 1995;9:157–66.PubMed
13.
Zurück zum Zitat Giorgetti A, Marzullo P, Sambuceti G, et al. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging. J Nucl Cardiol. 2004;11:142–51.CrossRef Giorgetti A, Marzullo P, Sambuceti G, et al. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging. J Nucl Cardiol. 2004;11:142–51.CrossRef
14.
Zurück zum Zitat Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539–42.CrossRef Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539–42.CrossRef
15.
Zurück zum Zitat Ficaro EP, Lee BC, Kritzman JN, et al. Corridor4DM: the Michigan method for quantitative nuclear cardiology. J Nucl Cardiol. 2007;14:455–65.CrossRef Ficaro EP, Lee BC, Kritzman JN, et al. Corridor4DM: the Michigan method for quantitative nuclear cardiology. J Nucl Cardiol. 2007;14:455–65.CrossRef
16.
Zurück zum Zitat Gimelli A, Rovai I, Liga R, et al. Appropriate use criteria in clinical routine practice: implications in a nuclear cardiology lab. Int J Card Imaging. 2016;32:1003–9.CrossRef Gimelli A, Rovai I, Liga R, et al. Appropriate use criteria in clinical routine practice: implications in a nuclear cardiology lab. Int J Card Imaging. 2016;32:1003–9.CrossRef
17.
Zurück zum Zitat Acampa W, Buechel RR, Gimelli A. Low dose in nuclear cardiology: state of the art in the era of new cadmium-zinc-telluride cameras. Eur Heart J Cardiovasc Imaging. 2016;17:591–5.CrossRef Acampa W, Buechel RR, Gimelli A. Low dose in nuclear cardiology: state of the art in the era of new cadmium-zinc-telluride cameras. Eur Heart J Cardiovasc Imaging. 2016;17:591–5.CrossRef
18.
Zurück zum Zitat Gimelli A, Liga R, Duce V, et al. Accuracy of myocardial perfusion imaging in detecting multivessel coronary artery disease: a cardiac CZT study. J Nucl Cardiol. 2017;24:687–95.CrossRef Gimelli A, Liga R, Duce V, et al. Accuracy of myocardial perfusion imaging in detecting multivessel coronary artery disease: a cardiac CZT study. J Nucl Cardiol. 2017;24:687–95.CrossRef
19.
Zurück zum Zitat Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72:2231–64.CrossRef Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72:2231–64.CrossRef
20.
Zurück zum Zitat Neglia D, Liga R, Caselli C, et al. Anatomical and functional coronary imaging to predict long-term outcome in patients with suspected coronary artery disease: the EVINCI-outcome study. Eur Heart J Cardiovasc Imaging. 2019:jez248. Neglia D, Liga R, Caselli C, et al. Anatomical and functional coronary imaging to predict long-term outcome in patients with suspected coronary artery disease: the EVINCI-outcome study. Eur Heart J Cardiovasc Imaging. 2019:jez248.
21.
Zurück zum Zitat Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710–8.CrossRef Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710–8.CrossRef
22.
Zurück zum Zitat Buckberg GD, Athanasuleas CL. The STICH trial: misguided conclusions. J Thorac Cardiovasc Surg. 2009;138:1060–1064.e2.CrossRef Buckberg GD, Athanasuleas CL. The STICH trial: misguided conclusions. J Thorac Cardiovasc Surg. 2009;138:1060–1064.e2.CrossRef
23.
Zurück zum Zitat Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450–6.CrossRef Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450–6.CrossRef
24.
Zurück zum Zitat Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–55.CrossRef Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–55.CrossRef
25.
Zurück zum Zitat Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–7. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–7.
26.
Zurück zum Zitat CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13.CrossRef CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13.CrossRef
27.
Zurück zum Zitat Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709–17.CrossRef Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709–17.CrossRef
28.
Zurück zum Zitat McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004.CrossRef McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004.CrossRef
29.
Zurück zum Zitat McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995–2008.CrossRef McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995–2008.CrossRef
30.
Zurück zum Zitat Berman DS, Abidov A, Kang X, et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol. 2004;11:414–23.CrossRef Berman DS, Abidov A, Kang X, et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol. 2004;11:414–23.CrossRef
Metadaten
Titel
Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction
verfasst von
Alessia Gimelli
Alberto Aimo
Emilio Maria Pasanisi
Michele Alessandro Coceani
Alberto Clemente
Michele Emdin
Leslee J. Shaw
Publikationsdatum
18.03.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2021
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-021-05312-4